Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

Poseida Therapeutics, Inc. Common Stock (PSTX)

Biological Products, (no Disgnostic Substances)

https://www.poseida.com

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

9390 TOWNE CENTRE DRIVE, SUITE 200
SAN DIEGO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/10/2020

Market Cap

280,231,302

Shares Outstanding

95,620,000

Weighted SO

95,624,439

Total Employees

N/A

Upcoming Earnings

08/13/2024

Beta

0.5250

Last Div

0.0000

Range

1.83-4.27

Chg

-0.0350

Avg Vol

441159

Mkt Cap

280231302

Exch

NASDAQ

Country

US

Phone

858 779 3100

DCF Diff

2.5571

DCF

-0.0072

Div Yield

0.0000

P/S

3.1678

EV Multiple

-2.4509

P/FV

4.5998

Div Yield %

0.0000

P/E

-2.5109

PEG

-0.2024

Payout

0.0000

Current Ratio

2.4829

Quick Ratio

2.4829

Cash Ratio

0.2982

DSO

51.2746

DIO

0.0000

Op Cycle

51.2746

DPO

130.7163

CCC

-79.4416

Gross Margin

0.9056

Op Margin

-1.3392

Pretax Margin

-1.2736

Net Margin

-1.2594

Eff Tax Rate

0.0427

ROA

-0.3730

ROE

-1.1955

ROCE

-0.6036

NI/EBT

0.9889

EBT/EBIT

0.9510

EBIT/Rev

-1.3392

Debt Ratio

0.2171

D/E

1.0661

LT Debt/Cap

0.4916

Total Debt/Cap

0.5160

Int Coverage

9.2220

CF/Debt

0.0379

Equity Multi

4.9112

Rec Turnover

7.1185

Pay Turnover

2.7923

Inv Turnover

0.0000

FA Turnover

2.3452

Asset Turnover

0.2962

OCF/Share

0.0254

FCF/Share

0.0022

Cash/Share

2.4526

OCF/Sales

0.0278

FCF/OCF

0.0862

CF Coverage

0.0379

ST Coverage

0.4072

CapEx Coverage

1.0943

Div&CapEx Cov

1.0943

P/BV

4.5998

P/B

4.5998

P/S

3.1678

P/E

-2.5109

P/FCF

1321.8395

P/OCF

113.7634

P/CF

113.7634

PEG

-0.2024

P/S

3.1678

EV Multiple

-2.4509

P/FV

4.5998

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation